Shortcuts

open access

Vol 2, No 4 (2006)
Prace poglądowe
Published online: 2007-01-25
Get Citation

May prior Chlamydia pneumoniae infection may determine the development of chronic inflamation in obesity?

Monika Koziołek, Barbara Krzyżanowska-Świniarska, Tomasz Miazgowski, Krystyna Pilarska
Endokrynol. Otył. Zab. Przem. Mat 2006;2(4):129-133.

open access

Vol 2, No 4 (2006)
Prace poglądowe
Published online: 2007-01-25

Abstract

Obesity is associated with a mild and chronic inflammatory process. There is increasing evidence that in obesity the adipocytes secrete numerous bioactive substances, such as CRP, IL-6, TNF-α, leptin and adiponectin. Thus, adipose tissue actively contributes in the development of inflammatory response. Among many theories elucidating subclinical, chronic inflammatory process in obesity, relatively less is known about possible bacterial infection in the initiation of this process and in modulation of its course. Does intracellular bacteria Chlamydia pneumonia, associated with the progression of atheromatosis which has been considered recently as a vascular inflammatory disease, might be a factor initiating the cytokine cascade in obesity? This bacterium may infect and live in number of the host cells (including circulating monocytes, tissue macrophages, or endothelial cells). If human immune system is unable to eliminate Chlamydia pneumoniae, the inflammation progresses to a self-supporting chronic process, in which are essentially involved macrophages infiltrating fat tissue, increased synthesis of the pro-inflammatory cytokines, and C-reactive protein in adipose cells as a reaction of the body for prolonged antigen stimulation.

Abstract

Obesity is associated with a mild and chronic inflammatory process. There is increasing evidence that in obesity the adipocytes secrete numerous bioactive substances, such as CRP, IL-6, TNF-α, leptin and adiponectin. Thus, adipose tissue actively contributes in the development of inflammatory response. Among many theories elucidating subclinical, chronic inflammatory process in obesity, relatively less is known about possible bacterial infection in the initiation of this process and in modulation of its course. Does intracellular bacteria Chlamydia pneumonia, associated with the progression of atheromatosis which has been considered recently as a vascular inflammatory disease, might be a factor initiating the cytokine cascade in obesity? This bacterium may infect and live in number of the host cells (including circulating monocytes, tissue macrophages, or endothelial cells). If human immune system is unable to eliminate Chlamydia pneumoniae, the inflammation progresses to a self-supporting chronic process, in which are essentially involved macrophages infiltrating fat tissue, increased synthesis of the pro-inflammatory cytokines, and C-reactive protein in adipose cells as a reaction of the body for prolonged antigen stimulation.
Get Citation

Keywords

obesity; Chlamydia pneumoniae; inflammatory markers; macrophages

About this article
Title

May prior Chlamydia pneumoniae infection may determine the development of chronic inflamation in obesity?

Journal

Endocrinology, Obesity and Metabolic Disorders

Issue

Vol 2, No 4 (2006)

Pages

129-133

Published online

2007-01-25

Page views

849

Article views/downloads

5445

Bibliographic record

Endokrynol. Otył. Zab. Przem. Mat 2006;2(4):129-133.

Keywords

obesity
Chlamydia pneumoniae
inflammatory markers
macrophages

Authors

Monika Koziołek
Barbara Krzyżanowska-Świniarska
Tomasz Miazgowski
Krystyna Pilarska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk,

tel. +48 58 320 94 94, faks +48 58 320 94 94, e-mail:  viamedica@viamedica.pl